CVRX CVRx, Inc.
CVRx, Inc. (CVRX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $534.3K.
Where they traded
Last open-market purchase: August 13, 2026 , by Binkowski Brent .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Binkowski Brent | CHIEF OPERATING OFFICER | Buy | 26,223 | $2.91 | $76.4K | 56,514 | |
| Binkowski Brent | CHIEF OPERATING OFFICER | Sell | 1,309 | $2.55 | $3.3K | 30,291 −4.1% of holding | |
| Hykes Kevin | PRES & CEO | Sell | 7,763 | $7.90 | $61.3K | 284,237 −2.7% of holding | |
| John Robert Allen | Chief Revenue Officer | Sell | 3,964 | $7.90 | $31.3K | 86,036 −4.4% of holding | |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | Sell | 1,744 | $7.90 | $13.8K | 96,703 −1.8% of holding | |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,284 | $7.90 | $10.1K | 60,551 −2.1% of holding | |
| Adamson Philip B. | Chief Medical Officer | Sell | 1,262 | $7.90 | $10.0K | 61,578 −2% of holding | |
| Jain Mudit K. | Director | Buy | 46,800 | $6.36 | $297.6K | 980,183 | |
| Jain Mudit K. | Director | Buy | 600 | $4.64 | $2.8K | 5,650 | |
| 2 fills | Sell | 12,674 | $10.03 | $127.1K | 4,040,861 −0.3% of holding | ||
| Sell | 16,000 | $10.03 | $160.5K | 4,031,198 −0.4% of holding | |||
| Sell | 2,200 | $10.06 | $22.1K | 4,047,198 −0.1% of holding | |||
| Sell | 500 | $10.00 | $5.0K | 4,049,398 −0% of holding | |||
| Sell | 1,000 | $10.00 | $10.0K | 4,049,898 −0% of holding | |||
| Sell | 200 | $10.00 | $2.0K | 4,050,898 −0% of holding | |||
| Sell | 52,332 | $10.21 | $534.3K | 4,051,098 −1.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.